Lobbying client
CRUCELL SWITZERLAND AG
Biopharmaceutical company owned by J&J that develops, produces, and markets vaccines
Filings
5
Filed by
1
Reported in-house
—
Reported by firms
$60,000
Filings
5 filings, newest first.
| Filing | Filed by | Amount |
|---|---|---|
|
4th Quarter - Termination Amendment 4th Quarter 2011
|
HAAKE & ASSOCIATES | $20,000 reported |
|
4th Quarter - Reportreplaced 4th Quarter 2011
|
HAAKE & ASSOCIATES | $20,000 reported |
|
3rd Quarter - Report 3rd Quarter 2011
|
HAAKE & ASSOCIATES | $20,000 reported |
|
2nd Quarter - Report 2nd Quarter 2011
|
HAAKE & ASSOCIATES | $20,000 reported |
|
Registration 2nd Quarter 2011
|
HAAKE & ASSOCIATES | — reported |
Filed by
Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.
| Firm | Reports | Amount |
|---|---|---|
| HAAKE & ASSOCIATES | 3 | $60,000 |
Issues lobbied
How many report sections named each issue, counting the current version of each report.
| Issue | Code | Mentions |
|---|---|---|
| Foreign Relations | FOR | 4 |
| Health Issues | HCR | 4 |
| Medical/Disease Research/Clinical Labs | MED | 2 |
| Pharmacy | PHA | 1 |
From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.